(Q37798155)

23 August 2017

Pulmonary hypertension with left-sided heart disease (English)

1 reference

23 August 2017

arterial hypertension

0 references

pulmonary hypertension

1 reference

Ross Arena

2

0 references

Marco Guazzi

object named as

Marco Guazzi

series ordinal

1

0 references

language of work or name

English

0 references

publication date

5 October 2010

1 reference

Nature Reviews Cardiology

23 August 2017

1 reference

23 August 2017

7

1 reference

23 August 2017

11

1 reference

23 August 2017

648-659

1 reference

Vulnerability of pulmonary capillaries in heart disease.

23 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Morpho-functional analysis of lung tissue in mild interstitial edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Composition, biophysical properties, and morphometry of plasma membranes in pulmonary interstitial edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Influence of pulmonary capillary wedge pressure on central apnea in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Congestion in acute heart failure syndromes: an essential target of evaluation and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The pathogenesis of acute pulmonary edema associated with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Clinical practice. Diastolic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Prognostic importance of pulmonary hypertension in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Alveolar gas diffusion abnormalities in heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Phenotypic heterogeneity of the endothelium: II. Representative vascular beds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Ultrastructural appearances of pulmonary capillaries at high transmural pressures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Plasma surfactant protein-B: a novel biomarker in chronic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Ultrastructure of the alveolar-capillary wall in mitral stenosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Alveolar--capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The evolving management of acute right-sided heart failure in cardiac transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Signaling molecules in nonfamilial pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Endothelin receptor subtypes in human versus rabbit pulmonary arteries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Endothelin receptor blockers in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Determinants of pulmonary hypertension in left ventricular dysfunction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Haemodynamic evaluation of pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Partitioning of pulmonary vascular resistance in primary pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

How the left and right sides of the heart, as well as pulmonary venous drainage, adapt to an increasing degree of head-up tilting in hypertrophic cardiomyopathy: differences from the normal heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Apparent paradox of neurohumoral axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Right ventricular ejection fraction: An indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Prognostic Importance of Various Echocardiographic Right Ventricular Functional Parameters in Patients with Symptomatic Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Right ventricular dysfunction and adverse outcome in patients with advanced heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Heart failure with preserved ejection fraction: invasive solution to diagnostic confusion?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary hypertension associated with left ventricular diastolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary hypertension in heart failure with preserved ejection fraction any pathophysiological role of mitral regurgitation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Exercise-induced pulmonary arterial hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Pulmonary hypertension and exercise intolerance in patients with heart failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Development of a ventilatory classification system in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Exercise Oscillatory Ventilation May Predict Sudden Cardiac Death in Heart Failure Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Effects of acute changes in pulmonary wedge pressure on periodic breathing at rest in heart failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Prostacyclin therapy in patients with congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Clinical and Hemodynamic Effects of Bosentan Dose Optimization in Symptomatic Heart Failure Patients with Severe Systolic Dysfunction, Associated with Secondary Pulmonary Hypertension – A Multi-Center Randomized Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Randomized, Double-Blind Trial of Inhaled Nitric Oxide in LVAD Recipients With Pulmonary Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Sildenafil citrate therapy for pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Clinical use of phosphodiesterase-5 inhibitors in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Long-term use of sildenafil in the therapeutic management of heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Left Ventricular Dyssynchrony Predicts Right Ventricular Remodeling After Cardiac Resynchronization Therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.144

Hemodynamic monitoring: invasive techniques

31 March 2020

1 reference

12 December 2020

Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.

1 reference

12 December 2020

Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema

1 reference

12 December 2020

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

1 reference

12 December 2020

EVE and beyond, retro and prospective insights

1 reference

12 December 2020

Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure

1 reference

12 December 2020

Pulmonary edema and elevated left atrial pressure: four hours and beyond

1 reference

12 December 2020

Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

1 reference

12 December 2020

10.1038/NRCARDIO.2010.144

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20924360